| Italian Population |
59,641,488 |
21 |
| Multiple sclerosis (MS) prevalence rate |
0.2% |
22 |
| Number of prevalent MS patients in the model |
119,283 |
Estimated
|
| SPMS prevalence |
13.7% |
18, 23 and expert opinion
|
| Number of subjects with SPMS |
16,342 |
Estimated
|
| Percentage of patients with SPMS age 18–60 and EDSS between 3–6.5 |
91.8% |
18, 23 and expert opinion
|
| Number of patients with SPMS age 18–60 and EDSS between 3–6.5 |
15,001 |
Estimated |
| Percentage of patients with active SPMS |
60.0% |
23 |
| Number of patients with active SPMS |
9,002 |
Estimated
|
| Percentage of patients with active SPMS and under-treatment |
65.0% |
21 |
| Number of patients with active SPMS and under-treatment |
5,851 |
Estimated
|
| Percentage of patients eligible for siponimod treatment |
99.6% |
24 |
| Number of patients eligible for siponimod treatment |
5,827 |
Estimated
|
